The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bayer; Exelixis; GlaxoSmithKline; Novartis; Pfizer
Consulting or Advisory Role - Bayer; Exelixis; GlaxoSmithKline; Novartis; Pfizer

Analysis of overall survival (OS) based on tumor target lesion change in the phase 3 METEOR trial of cabozantinib (cabo) versus everolimus (eve) in advanced renal cell carcinoma (RCC).
 
Sumanta K. Pal
Honoraria - Astellas Pharma; Medivation; Novartis
Consulting or Advisory Role - Aveo; Bristol-Myers Squibb; Exelixis; Genentech; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Exelixis; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Mayer N. Fishman
Honoraria - Alkermes; Altor BioScience; AVEO
Consulting or Advisory Role - Eisai
Speakers' Bureau - Exelixis; Pfizer; Prometheus
Research Funding - Altor BioScience; Amgen; Bayer; Bristol-Myers Squibb; Eisai; Genentech; GlaxoSmithKline; Pfizer
 
Raymond S. McDermott
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen; Merck Sharp & Dohme; Novartis; Pfizer; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Jose Passos-Coelho
Consulting or Advisory Role - Janssen; Novartis; Roche
Travel, Accommodations, Expenses - Celgene; Janssen; Roche
 
Evgeniy Kopyltsov
No Relationships to Disclose
 
Xavier Garcia del Muro
Consulting or Advisory Role - Bayer; Pfizer
Speakers' Bureau - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Jesus Garcia Donas
No Relationships to Disclose
 
Ramazan Yildiz
No Relationships to Disclose
 
Lori Wood
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Pfizer (Inst); Roche Canada (Inst)
Travel, Accommodations, Expenses - Novartis
 
Pawel Zalewski
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Novartis; Sanofi
Research Funding - Bristol-Myers Squibb; Janssen; Novartis; Roche
 
Brian Addis Costello
No Relationships to Disclose
 
Walter Michael Stadler
Honoraria - AstraZeneca; Bayer; CVS Caremark; Johnson & Johnson; Merck; Sotio
Consulting or Advisory Role - AstraZeneca; Bayer; CVS Caremark; Johnson & Johnson; Merck; Sotio
Research Funding - Active Biotech (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Johnson & Johnson (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst)
Other Relationship - American Cancer Society; UpToDate
 
Timothy M Kuzel
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Eisai; Exelixis; Pfizer
Speakers' Bureau - Astellas Pharma; Bayer; Celgene; Sanofi
Research Funding - Amgen
 
Stephen K. Williamson
No Relationships to Disclose
 
Takeyoshi Alfonso Kondo
No Relationships to Disclose
 
David W Markby
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Bernard Escudier
No Relationships to Disclose
 
Thomas Powles
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Novartis
Research Funding - AstraZeneca/MedImmune; Roche/Genentech
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Pfizer; Prometheus; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)